JAK2 and myelofibrosis: Myelofibrosis is a myeloproliferative neoplasm associated with mutations in the cytoplasmic tyrosine kinase Janus kinase (JAK) 2, and dysregulation of the JAK/signal transducer and activator of transcription pathway [1].